Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think all the Form 4s filed by the CFO, in the last few weeks is interesting.
That is also a good question. I was just looking around to see what was going on.
What's the reason PPS was ever up? Mystifying
I see Donald Lundbom, CFO, sold a few thousand shares yesterday.
I am new to CBDS, anything important I need to know?
What's the reason the PPS has fallen? August it was $4.
Slated, as in predicted? Or foretold by soothsayers?
CBDS Slated to Rise to $11.00/share
1.) https://marijuanaindex.com/ indicates an industry-wide boom beginning
2.) Rises in associated North American recreational MJ companies
3.) Aggregate growth centered around California recreational boom, to begin with long lines of people buying for the first time from vendors in the State in 61 days, on 01JAN2018.
4.) CBDS rise slated to coincide with California demand
All broke useless garbage companies just like CBDS. Put them all together and they don't have a pot to urinate in or even a window to throw it out of.
Wow. I just came here from the other board to check the price of CBDS shares. This stock is going for 2.80?! Wow. Looks like the other one you are talking about has a potential too match this stock's price level.
International Endeavors Announces Agreement with Kubby Cryogenics, Inc. for Medical Marijuana Expansion
TEMECULA, CA -- (Marketwired) -- 10/13/17 -- International Endeavors Corporation (OTC: IDVV) ("IEC" is pleased to announce the Company has signed an MOU with Kubby Cryogenics Inc.
Under the terms of this agreement:
Steve Kubby will immediately become CEO of International Endeavor Corporation.
Kubby Cryogenics will look to patent medical grade cannabis strains that are genetically profiled to treating specific diseases.
The company will be acquiring licensing rights to patent new delivery systems in the future. Further, the company will continue with product development in their own proprietary Cryogenics line, which captures the highest medical value of any product known on the market today.
To accomplish these goals, Kubby Cryogenics has assembled a team of top Scientists and Geneticists to research and develop the strains for these Cryogenic Extract products.
Steve Kubby, commented, "We are very excited to partner with IEC, and anticipate bringing a new class of medicine to the market through our pure line of medical grade cannabis products featuring our patent pending Cryogenic process. We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products featuring a patent pending menu of powerful strains and pure, all natural, solvent-less concentrate products."
Cryogenics Medical Uses Cancer, Fibromyalgia, Arthritis, High Blood Pressure, Epilepsy, Brain Injury, Stroke, Inflammation, and PTSD.
Mr. Steve Kubby Bio Steven Wynn "Steve" Kubby played a key role in the passage of California Proposition 215, a ballot initiative passed in 1996 to legalize medical marijuana. He is a well-known cancer patient of 36 years, who benefits his recovery through the use of non-psychoactive Cryogenics, a raw cannabis extract. Steve Kubby was formally Chairman and CEO of Cannabis Sativa Inc., traded under the symbol CBDS, and has authored 2 books on drug policy reform. Mr. Kubby's distinguished political career includes runs for Governor of California in 1998, and the 2008 Presidential primary race under the libertarian ticket.
About International Endeavors Corporation International Endeavors Corporation is a company focused on biomedical uses of non-psychoactive cannabis based products for the treatment of a wide variety of illnesses. Through a unique patent pending Cryogenic process, the Company can process different unique medical grade cannabis strains that are genetically profiled to treating specific diseases. www.internationalendeavorscorp.com
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Nobia Kubby
Chief Operations Officer
Phone: 831-383-2141
Email: Nobia@kubbyinc.com
You say this, because you read an article? Have you done any DD on Steve Kubby??
Keep watching and you will see just how "great" that article about good old Kubby was...
IDVV Last trade .82, up 26%. The next BIG MJ play:
International Endeavors Announces Agreement with Kubby Cryogenics, Inc. for Medical Marijuana Expansion
TEMECULA, CA--(Marketwired - Oct 13, 2017) - International Endeavors Corporation (OTC: IDVV) ("IEC" is pleased to announce the Company has signed an MOU with Kubby Cryogenics Inc.
Under the terms of this agreement:
Steve Kubby will immediately become CEO of International Endeavor Corporation.
Kubby Cryogenics will look to patent medical grade cannabis strains that are genetically profiled to treating specific diseases.
The company will be acquiring licensing rights to patent new delivery systems in the future. Further, the company will continue with product development in their own proprietary Cryogenics line, which captures the highest medical value of any product known on the market today.
To accomplish these goals, Kubby Cryogenics has assembled a team of top Scientists and Geneticists to research and develop the strains for these Cryogenic Extract products.
Steve Kubby, commented, "We are very excited to partner with IEC, and anticipate bringing a new class of medicine to the market through our pure line of medical grade cannabis products featuring our patent pending Cryogenic process. We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products featuring a patent pending menu of powerful strains and pure, all natural, solvent-less concentrate products."
Cryogenics Medical Uses
Cancer, Fibromyalgia, Arthritis, High Blood Pressure, Epilepsy, Brain Injury, Stroke, Inflammation, and PTSD.
Mr. Steve Kubby Bio
Steven Wynn "Steve" Kubby played a key role in the passage of California Proposition 215, a ballot initiative passed in 1996 to legalize medical marijuana. He is a well-known cancer patient of 36 years, who benefits his recovery through the use of non-psychoactive Cryogenics, a raw cannabis extract. Steve Kubby was formally Chairman and CEO of Cannabis Sativa Inc., traded under the symbol CBDS, and has authored 2 books on drug policy reform. Mr. Kubby's distinguished political career includes runs for Governor of California in 1998, and the 2008 Presidential primary race under the libertarian ticket.
About International Endeavors Corporation
International Endeavors Corporation is a company focused on biomedical uses of non-psychoactive cannabis based products for the treatment of a wide variety of illnesses. Through a unique patent pending Cryogenic process, the Company can process different unique medical grade cannabis strains that are genetically profiled to treating specific diseases. www.internationalendeavorscorp.com
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Nobia Kubby
Chief Operations Officer
Phone: 831-383-2141
Email: Nobia@kubbyinc.com
Advertise Here
Steve Kubby ex ceo of CBDS and newly appointed CEO of IDVV has a great article out on him and his new company IDVV: http://www.wallstreetnewscast.com/idvv-1016/
When did he begin and when did he quit as CEO of Cannabis Sativa (CBDS)?
There isn't anything about Steve Kubby from a Google search. He says his CEO of KUSH Research, kushresearch.com. Click on it and it is an open website address.
His last posts on Facebook and Twitter were in September 2016.
Kubby the new IDVV CEO took CBDS from a few pennies to 13.00. IDVV is a much better company. Read today's NEWS.
Steve Kubby the EX-CEO of CBDS is now doing big things for IDVV. IDVV 10.00 Price target.
International Endeavors Announces Agreement with Kubby Cryogenics, Inc. for Medical Marijuana Expansion
TEMECULA, CA--(Marketwired - Oct 13, 2017) - International Endeavors Corporation (OTC: IDVV) ("IEC") is pleased to announce the Company has signed an MOU with Kubby Cryogenics Inc.
Under the terms of this agreement:
Steve Kubby will immediately become CEO of International Endeavor Corporation.
Kubby Cryogenics will look to patent medical grade cannabis strains that are genetically profiled to treating specific diseases.
The company will be acquiring licensing rights to patent new delivery systems in the future. Further, the company will continue with product development in their own proprietary Cryogenics line, which captures the highest medical value of any product known on the market today.
To accomplish these goals, Kubby Cryogenics has assembled a team of top Scientists and Geneticists to research and develop the strains for these Cryogenic Extract products.
Steve Kubby, commented, "We are very excited to partner with IEC, and anticipate bringing a new class of medicine to the market through our pure line of medical grade cannabis products featuring our patent pending Cryogenic process. We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products featuring a patent pending menu of powerful strains and pure, all natural, solvent-less concentrate products."
Cryogenics Medical Uses
Cancer, Fibromyalgia, Arthritis, High Blood Pressure, Epilepsy, Brain Injury, Stroke, Inflammation, and PTSD.
Mr. Steve Kubby Bio
Steven Wynn "Steve" Kubby played a key role in the passage of California Proposition 215, a ballot initiative passed in 1996 to legalize medical marijuana. He is a well-known cancer patient of 36 years, who benefits his recovery through the use of non-psychoactive Cryogenics, a raw cannabis extract. Steve Kubby was formally Chairman and CEO of Cannabis Sativa Inc., traded under the symbol CBDS, and has authored 2 books on drug policy reform. Mr. Kubby's distinguished political career includes runs for Governor of California in 1998, and the 2008 Presidential primary race under the libertarian ticket.
About International Endeavors Corporation
International Endeavors Corporation is a company focused on biomedical uses of non-psychoactive cannabis based products for the treatment of a wide variety of illnesses. Through a unique patent pending Cryogenic process, the Company can process different unique medical grade cannabis strains that are genetically profiled to treating specific diseases. www.internationalendeavorscorp.com
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Nobia Kubby
Chief Operations Officer
Phone: 831-383-2141
Email: Nobia@kubbyinc.com
And yet insiders of CBDS continue to sell off their shares on a regular basis. Form 4s indicating these sell offs are rampant here now.
Why I went Long CBDS with 50,000 Shares
1.) In about 50 days (January 1st, 2018) California Sells Recreational Marijuana to very long lines of people
2.) CBDS is expanding its base in California
3.) CBDS exhibiting consistent news, aligning with longterm shareholders
4.) Impending Congressional meetings on DEA rescheduling of MMJ and RMJ
5.) Consistent employee workload, and trustworthy management
Long time no see.
How have you been?
I still have lots of MJ stocks and hold tons of shale gas stocks. Problem is that most stocks are in red ink. But, that's fine because I am taking a long position and made money last year. I sold most of my MJ stocks on the same date when Californians voted for MJ legalization, or presidential election date.
22% tax by doggish Korean government. BMW 3 money... It was very painful.
If there is someone thinking of coming to Korea, coming is not at all, however living is a totally different issue. I don't recommend. Europe is the greatest, Japan is very nice, US is also good. The others.. mostly weird laws.
Anyway, I turned my eyes to cryptocurrencies. I wonder whether or not ordinary Americans are interested in Bitcoins or ETH, etc. Just very curious. In Korea, it is booming only to about 1-3%. Most people do not know what the Bitcoin is. I wonder the situation of US. Just curious.
I collected 3 bitcoins and 80 ETHs and 50,000 Ripples for 4 months because I jumped in this sector too late. What an airhead!
Just extremely curious. therefore please don't blame me for asking the cryptocurrencies in the stock website. Chow!
Kinda seems like this will be the norm for the entirety of Trumps reign. Good thing CBDS has started woking with digital technologies, people are extremely interested in marijuana - regardless of the legality of it - and those people will continue to visit related websites regardless of whether or not they live in a legal State...
HEMP, GRWG, CBDS, CBDG, WEDG: SEC Admin Proceeding against Honeysuckle Research Inc./ticker WEDG:
https://www.sec.gov/litigation/admin/2017/ic-32840.pdf
Excerpts:
1. Beginning in December 2014, Honeysuckle primarily engaged in the business of investing and trading in securities, and more than 40% of its total assets (other than Government securities and cash items) consisted of investment securities as defined by Section 3(a)(2) of the Investment Company Act. The company has no operating business and has never realized an operating profit or revenue. As of January 3, 2017, Honeysuckle’s investment securities had a value of over $9.4 million constituting about 88% of Honeysuckle’s total assets (exclusive of Government securities and cash items). As a result, Honeysuckle has been and is in violation of Section 7(a) of the Investment Company Act.
2. Honeysuckle Research Inc. is a Nevada corporation headquartered in Woodland Hills, California. In July 2013, Honeysuckle’s predecessor company, Ovation Research, Inc. (“Ovation”), filed a Form S-1 with the Commission to register a class of securities for offer and sale to the public. The Form S-1 went effective on December 5, 2013. Its shares are currently quoted on OTC Link (formerly “Pink Sheets”) operated by OTC Markets Group (“OTC Link”), under the symbol (OTCPINK:WEDG). Honeysuckle and its predecessor companies have never been registered with the Commission as an investment company.
Facts
3. In December 2012, Honeysuckle started as a company named Ovation, which purported to distribute stainless steel cookware. In September 2014, Ovation changed its name to Weed Growth Fund, Inc. and, as stated in its Form 10-Q filed in January 2015, changed its business model to the establishment and investment in, and the acquisition, operation and management of, intellectual property and business ventures in hemp, medicinal cannabis, legalized cannabis and related industries. In April 2016, Weed Growth changed its name to Honeysuckle, but maintained the same business model.
4. In December 2014, Honeysuckle acquired non-controlling interests in various hemp-related companies quoted on OTC Link (formerly “Pink Sheets”) operated by OTC Markets Group, Inc., including Hemp, Inc. (OTCPINK: HEMP), Grow Condos, Inc. (OTCQB: GRWC), and Cannabis Sativa, Inc. (OTCQB: CBDS) by purchasing the common stock of these companies. Honeysuckle also acquired a majority interest in THC Farmaceuticals, Inc. (OTCQB: CBDG). Honeysuckle acquired the majority of these interests by exchanging the shares for non-controlling shares of Honeysuckle. In 2014 and 2015, Honeysuckle also purchased investment securities in three privately-owned companies. Honeysuckle paid a total of $710,000 for the private investment securities and non-controlling interests in three of the OTC Link companies. As of January 3,2017, the total combined value of these investments was $9,431,453.
5. Honeysuckle’s other assets total about $1.3 million and comprise various fixed assets (furniture, hardware and software) and a few non-securities related investments that have not produced any operating revenue. Honeysuckle has had no revenue since at least December 2014.
6. In 2015, the staff from the Division of Corporation Finance and the Division of Investment Management requested information from Honeysuckle concerning whether it was an investment company as defined by the Investment Company Act and whether any registration exemption or exclusion applied. Honeysuckle did not respond to staff comments in a timely manner.
(more at link)
Violation
10. As a result of the conduct described above, Honeysuckle is violating Section 7(a) of the Investment Company Act, which makes it unlawful for an unregistered investment company to, among other things, “directly or indirectly offer for sale, sell, or deliver after sale, by the use of the
mails or any means or instrumentality of interstate commerce, any security or any interest in a security” or “engage in any business in interstate commerce.”
Undertakings
11. Within 60 days of the institution of the Order, Respondent Honeysuckle shall come into compliance with Section 7(a) of the Investment Company Act by either:
a. Filing a notification of registration pursuant to Section 8(a) of the Investment Company Act, and then within 90 days of filing such notification of registration, filing a registration statement with the Commission, on the appropriate form; or
b. Completing steps such that Honeysuckle is no longer required to be registered under Section 7(a) of the Investment Company Act and providing the Commission staff with sufficient credible evidence that it is no longer required to be registered under the Investment Company Act.
(more at link)
Check out the SEC cease and desist order of September 28th against Honeysuckle Research Inc OTC WEDG and their involvement with CBDS and others.
Another anti-cannabis crusader bites the dust!
Health and Human Services Secretary Tom Price resigns
https://www.washingtonpost.com/news/post-politics/wp/2017/09/29/trump-to-decide-friday-night-whether-to-fire-hhs-secretary-price
I could see CBDS getting in on this, a quality organic weed wine.
Want to try weed wine? You’re in luck if you live in California
http://www.sanluisobispo.com/living/food-drink/article174077661.html
"Marijuana-infused wine has become quite popular in California. So much so that it’s tough to find vendors who have it in stock."
CBDS = Constant Bullshit Dissing Shareholders.
Yeah, fat chance. Chart shows a lot of support at this level. The bottom is here, in my opinion. I suspect we'll see a post-Labor day rise across the sector next week.
Wishful thinking
Go down some more so that i can afford this at a lower price. Someone short it some more. make it go down 90 cents
hey hey! So it took forever, but this manipulated stock has finally started moving to what it's really worth (nothing). Hopefully, Tobias, Barrameda, et al will also have to disgorge profits. This was an obviously manipulated stock last year. Maybe someone finally put a stop to some of it manipulation, and this is what happened.
watching this
2.00 buy target
$441,469 in cash, patented strain, Presto Doctor rockin' solid amid Sessions’ stance of targeting recreational marijuana. Long on CBDS as increased revenues sure to follow! Looking forward to a big second half of the year bounce-back. Goodbye summer - you were fun, but let's all get back to work...
CANNABIS SATIVA INC :: 10-Q :: 8/14/2017 --> http://ih.advfn.com/p.php?pid=nmona&article=75447597
Sessions promises of pot crackdown up in smoke
http://www.foxnews.com/politics/2017/08/08/sessions-promises-pot-crackdown-up-in-smoke.html
"The betting was that law-and-order Attorney General Jeff Sessions would come out against the legalized marijuana industry with guns blazing. But the task force Sessions assembled to find the best legal strategy is giving him no ammunition, according to documents obtained by The Associated Press."
http://www.chicagotribune.com/news/nationworld/politics/ct-attorney-general-marijuana-20170804-story.html
I was hoping that since GRWC is approaching zero, that those scamsters would take KUSH public soon
Another Gary Johnson pot scam.....I wonder if he funded his bogus presidential bid from CBDS.
Wow! Look at all those Form 4s stock sales filed by the insiders of CBDS over the last year and half or so. All sells by insiders and no buys. Doesnt instill much faith in the company does it.
Guess they could see the falling PPS well in advance of Joe six pack investor.
Excellent news!! Kyle Powers has done a lot of interesting work in tech too. Looking forward to trying this out.
Cannabis Sativa Acquires 51% of PrestoDoctor, A Premier Medical Marijuana Telemedicine Platform
http://cannabissativainc.com/cannabis-sativa-acquires-51-percent-prestodoctor/
Cory Booker is at it again!
U.S. Sen. Cory Booker introduces bill to legalize marijuana nationwide
“This is the single most far-reaching marijuana bill that’s ever been filed in either chamber of Congress,” Tom Angell, chairman of the group Marijuana Majority, said in a statement."
http://www.politico.com/states/new-jersey/story/2017/08/01/booker-seeks-federal-marijuana-legalization-113716
Massachusetts makes recreational cannabis official:
Massachusetts governor signs bill to allow recreational pot
http://thehill.com/homenews/state-watch/344343-massachusetts-governor-signs-bill-to-allow-recreational-pot
Meanwhile, the global movement toward cannabis legalization marches ahead:
https://qz.com/1041932/maneka-gandhi-one-of-narendra-modis-ministers-wants-to-make-marijuana-legal-in-india/
Especially given this:
Senate Committee Ignores Sessions, Protects Medical Marijuana
http://freebeacon.com/issues/committee-ignores-sessions-protects-medical-marijuana/
Still nothing about cracking down on cannabis from Jeff Sessions' Task Force on Crime Reduction
http://marijuanapolitics.com/jeff-sessions-currently-silent-new-marijuana-policy/
Although an attempt to crack down now would probably be the end of his term as AG.
Hopefully the new CFO can help CBDS step it up a notch, and sure am glad summer's almost over...
Looks like CBDS needs a new CFO to keep track of those mounting losses. Its going to be a difficult task for sure.
I hear ya, was wondering about it myself. I cannot find any info on them. Hopefully someone can can enlighten us.
Followers
|
186
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4801
|
Created
|
04/23/12
|
Type
|
Free
|
Moderators |
MESQUITE, NV / ACCESSWIRE / August 2, 2017 / Cannabis Sativa. Inc. (OTCQB:CBDS) announced today that the Company has acquired a controlling interest in PrestoCorp (a.k.a. PrestoDoctor), an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology (https://prestodoctor.com).
Appointments through PrestoDoctor’s website are generally completed in 10-15 minutes, and can be scheduled and completed in the same day. This convenience eliminates the need for patients to travel to an in-person appointment or wait in line at a clinic. More than 40,000 users have registered to consult with PrestoDoctor’s 15+ licensed physicians across the United States. PrestoDoctor currently offers services in California and Nevada, and is actively targeting expansion into multiple additional states in the coming months.
President David Tobias says:
“We are pleased to bring PrestoDoctor on board as a subsidiary of Cannabis Sativa. Combining our resources should be a great benefit to both companies. We are eager to assist PrestoDoctor in the roll out of their medical marijuana programs in several new states this year, and hope to see the continued growth of PrestoDoctor for years to come. We believe telemedicine is the future.”
PrestoDoctor was founded by an experienced Silicon Valley based team, with Kyle Powers previously at Google,IBM, PayPal, and ClearSlide, and Robert Tankson previously with Google, ClearSlide, and McCullough & Associates.
MESQUITE, NV / ACCESSWIRE / December 21, 2016 / Cannabis Sativa, Inc. (CBDS) announced that on December 20, 2016, the company's subsidiary was awarded Patent PP27,475 for a Cannabis Plant named "Ecuadorian Sativa".
"Equadorian Sativa" has been shown in laboratory testing by Steephill Labs to have a Limonene level that is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets "Equadorian Sativa" apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.
The objective of the breeding, which produced this novel plant strain nicknamed "CTA", was primarily to develop a plant having the following characteristics: (a) medicinal properties that included hypotensive activity; (b) psychoactive properties that motivated and energized, rather than creating lethargy, sleepiness, and (c) increased food consumption.
Anecdotally, there are indications that its use may prevent some cancers and may cause apoptosis of cancer cells in vivo. There is a good possibility that the high levels of limonene may slow down the build-up of plaque in the arteries and reduce the effect of low-density lipo-proteins on the circulatory system. Indications are that "Ecuadorian Sativa" has many medical qualities that make it an important tool to maintain health and deal with illness.
"Our patience is now rewarded with the issuance of Patent PP27,475". "This patent will open up new areas for research and opportunities for CBDS", said CEO Mike Gravel.
This plant was derived from a female said to be of a strain called colloquially, "Celestial Temple Sativa" an individual grown in Ecuador that as a solitary plant reached a height of 23 feet. The male parent is said to have been of a strain known colloquially as "Island Sweet Skunk".
The Company's President David Tobias said, "This is a major accomplishment and is a tribute to the foresight and perseverance of management to solidify Cannabis Sativa's contribution to the maturing Cannabis industry."
Cannabis Sativa, Inc. (OTCQB:CBDS) has global ambitions. We believe cannabis is destined to become the next gold rush, and we're prepared to help shape its future in a legal environment.
We've assembled the team, the talent and the experience necessary to brand and market the highest-quality cannabis products available today – and to innovate the future of casual cannabis.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |